
Home » Aethlon Medical Submits IDE to FDA for Hepatitis-C Study
Aethlon Medical Submits IDE to FDA for Hepatitis-C Study
Aethlon Medical submitted an investigational device exemption, or IDE, to the FDA requesting permission to initiate a clinical feasibility study of Hepatitis-C, or HCV, infected individuals enrolled to receive Hemopurifier therapy.
Equities
Equities
Upcoming Events
-
08Sep
-
14Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep